Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Early Mechanisms of Chemoresistance in Retinoblastoma.
Cancers (Basel). 2022 Oct 10;14(19):4966. doi: 10.3390/cancers14194966.
Cancers (Basel). 2022.
PMID: 36230889
Free PMC article.
Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.
Baqai U, Purwin TJ, Bechtel N, Chua V, Han A, Hartsough EJ, Kuznetsoff JN, Harbour JW, Aplin AE.
Baqai U, et al. Among authors: kuznetsoff jn.
Mol Cancer Res. 2022 Aug 5;20(8):1260-1271. doi: 10.1158/1541-7786.MCR-21-0657.
Mol Cancer Res. 2022.
PMID: 35426938
Free PMC article.
Item in Clipboard
RB1 loss triggers dependence on ESRRG in retinoblastoma.
Field MG, Kuznetsoff JN, Zhang MG, Dollar JJ, Durante MA, Sayegh Y, Decatur CL, Kurtenbach S, Pelaez D, Harbour JW.
Field MG, et al. Among authors: kuznetsoff jn.
Sci Adv. 2022 Aug 19;8(33):eabm8466. doi: 10.1126/sciadv.abm8466. Epub 2022 Aug 19.
Sci Adv. 2022.
PMID: 35984874
Free PMC article.
Item in Clipboard
BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas.
Kaler CJ, Dollar JJ, Cruz AM, Kuznetsoff JN, Sanchez MI, Decatur CL, Licht JD, Smalley KSM, Correa ZM, Kurtenbach S, Harbour JW.
Kaler CJ, et al. Among authors: kuznetsoff jn.
Cancers (Basel). 2022 Jul 28;14(15):3678. doi: 10.3390/cancers14153678.
Cancers (Basel). 2022.
PMID: 35954340
Free PMC article.
Item in Clipboard
Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.
Kuznetsoff JN, Owens DA, Lopez A, Rodriguez DA, Chee NT, Kurtenbach S, Bilbao D, Roberts ER, Volmar CH, Wahlestedt C, Brothers SP, Harbour JW.
Kuznetsoff JN, et al.
Mol Cancer Res. 2021 Feb;19(2):215-222. doi: 10.1158/1541-7786.MCR-20-0434. Epub 2020 Oct 19.
Mol Cancer Res. 2021.
PMID: 33077485
Free PMC article.
Item in Clipboard
Cite
Cite